Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Vaccine study aims to unlock secrets of Long-Term immunity

NCT ID NCT05272735

First seen Apr 19, 2026 · Last updated May 22, 2026 · Updated 4 times

Summary

This study looked at how the hepatitis B vaccine triggers the body's immune system, specifically focusing on memory B cells that help provide long-lasting protection. Healthy volunteers who had never been vaccinated against hepatitis B received the vaccine, and researchers analyzed samples from lymph nodes to understand how these memory cells respond to booster doses. The goal was to learn how to design better vaccines for fast-changing viruses like flu and HIV.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • The Rockefeller University

    New York, New York, 10065, United States

Conditions

Explore the condition pages connected to this study.